<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01286129</url>
  </required_header>
  <id_info>
    <org_study_id>FP-2005-3</org_study_id>
    <secondary_id>CER1223</secondary_id>
    <nct_id>NCT01286129</nct_id>
  </id_info>
  <brief_title>Nasal Allergen Challenge in Rhinitic Subjects</brief_title>
  <official_title>Comparative Responses to Nasal Allergen Challenge in Allergic Rhinitic Subjects With or Without Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AllerGen NCE Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Nasal allergen challenge (NAC) is useful to study the pathophysiology of
      rhinitis, and multiple challenges may more adequately approximate natural exposure.

      Objective: To determine the effect of 4 consecutive daily NAC, on clinical and inflammatory
      parameters in rhinitics with or without asthma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be performed outside the pollen season. On a baseline visit, 2 to 7 days prior
      to control challenge, allergy skin prick tests and methacholine inhalation test will be done.
      Prior to first allergen challenge, skin titration will be done using tenfold dilutions of the
      allergen chosen for nasal challenges. Subsequent to baseline visit, a control challenge will
      be done, followed, a week later, by repeated NACs. NACs will be done over 4 consecutive days,
      in the morning. Nasal peak inspiratory flows (NPIF), oral peak expiratory flows (PEF), and
      symptoms will be recorded at baseline and at regular intervals over 7 hours post-challenge on
      each challenge day. Induced sputum and nasal lavage specimen will be obtained 7 hours
      following the control challenge and the first and last NAC.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Sputum Eosinophils Following Allergen Challenge</measure>
    <time_frame>At 7 hours post first and last challenge compared to baseline</time_frame>
    <description>Eosinophil is an inflammatory cell found in the lungs. Sputum is obtained from hypertonic inhalation. patients expectorate in a sterile dish and mucus plugs are selected and treated to obtain cells. cells are transferred on a slide and a differential count is obtained where eosinophils are counted.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Nasal Lavage Eosinophils After Allergen Challenge</measure>
    <time_frame>At 7 hours post first and last challenge compared to baseline</time_frame>
    <description>Change in nasal lavage eosinophil percentages in allergic asthmatic and allergic non asthmatic at baseline and at 7h post first and last challenge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Asthma</condition>
  <condition>Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>Allergic asthmatic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with allergic asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Allergic rhinitic without asthma</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with allergic rhinitis without asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nasal allergen challenge</intervention_name>
    <description>Allergen sprayed into nostrils. Allergen used will be house dust mite or cat allergen. Allergens will be given in increasing ten-fold dilutions until a positive response occurs.</description>
    <arm_group_label>Allergic asthmatic</arm_group_label>
    <arm_group_label>Allergic rhinitic without asthma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  To have a positive reaction to one or more allergen on prick tests.

          -  Non smokers

          -  No respiratory track infection for at least one month prior to the study.

          -  Positive reaction to cat hair and/or house dust mite (Dermatophagoides pteronyssinus)
             aeroallergens on allergy skin prick tests and report rhinitis symptoms when exposed to
             an environment containing this allergen.

          -  Asthmatic subjects using only inhaled beta-2 agonists on an as needed basis for their
             asthma treatment.

          -  Asthmatic subjects with a history of asthma of at least 6 months.

          -  Asthmatic subjects with PC20 methacholine lower or equal to 8 mg/ml.

          -  Allergic rhinitic subjects never experienced any asthma symptoms or took any asthma
             medication in the past.

          -  Allergic rhinitic subjects with a provocative concentration of methacholine (PC20
             higher than 16 mg/ml.

        Exclusion Criteria:

          -  Smokers or ex smokers less than 6 months or more than 10 pack-years.

          -  Asthmatic subjects using or used in the past 3 months inhaled or oral corticosteroids.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louis-Philippe Boulet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut universitaire de cardiologie et de pneumologie de Québec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2011</study_first_submitted>
  <study_first_submitted_qc>January 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2011</study_first_posted>
  <results_first_submitted>March 29, 2012</results_first_submitted>
  <results_first_submitted_qc>May 24, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 1, 2013</results_first_posted>
  <last_update_submitted>May 24, 2013</last_update_submitted>
  <last_update_submitted_qc>May 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited from advertisement between November 2005 and october 2008</recruitment_details>
      <pre_assignment_details>After enrollment, there was a one to 7 days run-in period. Subjects that could not produce a quality sputum sample were excluded from the trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Allergic Asthmatic</title>
          <description>Subjects with allergic asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.</description>
        </group>
        <group group_id="P2">
          <title>Allergic Rhinitic Without Asthma</title>
          <description>Subjects with allergic rhinitis without asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Could not comply with study requirements</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Allergic Asthmatic</title>
          <description>Subjects with allergic asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.</description>
        </group>
        <group group_id="B2">
          <title>Allergic Rhinitic Without Asthma</title>
          <description>Subjects with allergic rhinitis without asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="45"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24" spread="4"/>
                    <measurement group_id="B2" value="24" spread="7"/>
                    <measurement group_id="B3" value="24" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Sputum Eosinophils Following Allergen Challenge</title>
        <description>Eosinophil is an inflammatory cell found in the lungs. Sputum is obtained from hypertonic inhalation. patients expectorate in a sterile dish and mucus plugs are selected and treated to obtain cells. cells are transferred on a slide and a differential count is obtained where eosinophils are counted.</description>
        <time_frame>At 7 hours post first and last challenge compared to baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Allergic Asthmatic</title>
            <description>Variation in sputum eosinophil percentage in allergic asthmatic between baseline value and at 7h following first and last challenge</description>
          </group>
          <group group_id="O2">
            <title>Allergic Rhinitic Without Asthma</title>
            <description>Variation in sputum eosinophil percentage in allergic non asthmatic between baseline value and at 7h following first and last challenge</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sputum Eosinophils Following Allergen Challenge</title>
          <description>Eosinophil is an inflammatory cell found in the lungs. Sputum is obtained from hypertonic inhalation. patients expectorate in a sterile dish and mucus plugs are selected and treated to obtain cells. cells are transferred on a slide and a differential count is obtained where eosinophils are counted.</description>
          <units>percentage of sputum eosinophils</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline percentage eosinophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="1.8"/>
                    <measurement group_id="O2" value="2.0" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7h post first challenge percentage eosinophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="1.7"/>
                    <measurement group_id="O2" value="1.3" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7h post last challenge percentage eosinophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="1.4"/>
                    <measurement group_id="O2" value="1.6" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Nasal Lavage Eosinophils After Allergen Challenge</title>
        <description>Change in nasal lavage eosinophil percentages in allergic asthmatic and allergic non asthmatic at baseline and at 7h post first and last challenge</description>
        <time_frame>At 7 hours post first and last challenge compared to baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Allergic Asthmatic</title>
            <description>Change in nasal lavage eosinophil percentages in allergic asthmatic at baseline and at 7h post first and last challenge</description>
          </group>
          <group group_id="O2">
            <title>Allergic Non Asthmatic</title>
            <description>Change in nasal lavage eosinophil percentages in allergic non asthmatic at baseline and at 7h post first and last challenge</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Nasal Lavage Eosinophils After Allergen Challenge</title>
          <description>Change in nasal lavage eosinophil percentages in allergic asthmatic and allergic non asthmatic at baseline and at 7h post first and last challenge</description>
          <units>percentage of nasal lavage eosinophils</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline percentage eosinophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="0.6"/>
                    <measurement group_id="O2" value="1.3" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7h post first challenge percentage eosinophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" spread="4.3"/>
                    <measurement group_id="O2" value="3.0" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7h post last challenge percentage eosinophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.7" spread="5.4"/>
                    <measurement group_id="O2" value="15.5" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Allergic Asthmatic</title>
          <description>Subjects with allergic asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.</description>
        </group>
        <group group_id="E2">
          <title>Allergic Rhinitic Without Asthma</title>
          <description>Subjects with allergic rhinitis without asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Louis-Philippe Boulet, principal investigator</name_or_title>
      <organization>IUCPQ</organization>
      <phone>418-656-4747</phone>
      <email>lpboulet@med.ulaval.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

